The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)
Open accessAbstract
In a multinational, double‐blind, placebo‐controlled trial (NCT00474058), 287 subjects with Parkinson's disease (PD) and unsatisfactory early‐morning motor symptom control were randomized 2:1 to receive rotigotine (2–16 mg/24 hr [n = 190]) or placebo (n = 97). Treatment was titrated to optimal dose over 1–8 weeks with subsequent dose maintenance for 4 weeks. Early‐morning motor function and nocturnal sleep disturbance were assessed as coprimary efficacy endpoints using the Unified Parkinson's Disease Rating Scale (UPDRS) Part III (Motor Examination) measured in the early morning prior to any medication intake and the modified Parkinson's Disease Sleep Scale (PDSS‐2) (mean change from baseline to end of maintenance [EOM], last observation carried forward). At EOM, mean UPDRS Part III score had decreased by −7.0 points with rotigotine (from a baseline of 29.6 [standard deviation (SD) 12.3] and by −3.9 points with placebo (baseline 32.0 [13.3]). Mean PDSS‐2 total score had decreased by −5.9 points with rotigotine (from a baseline of 19.3 [SD 9.3]) and by −1.9 points with placebo (baseline 20.5 [10.4]). This represented a significantly greater improvement with rotigotine compared with placebo on both the UPDRS Part III (treatment difference: −3.55 [95% confidence interval (CI) −5.37, −1.73]; P = 0.0002) and PDSS‐2 (treatment difference: −4.26 [95% CI −6.08, −2.45]; P < 0.0001). The most frequently reported adverse events were nausea (placebo, 9%; rotigotine, 21%), application site reactions (placebo, 4%; rotigotine, 15%), and dizziness (placebo, 6%; rotigotine 10%). Twenty‐four‐hour transdermal delivery of rotigotine to PD patients with early‐morning motor dysfunction resulted in significant benefits in control of both motor function and nocturnal sleep disturbances. © 2010 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, K. R., & Schapira, A. H. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,738
Self-citationUnified Parkinson's disease rating scale characteristics and structure
Martínez‐Martín, P., Gil‐Nagel, A., Gracia, L. M., Gómez, J. B., Martínez‐Sarriés, J., Bermejo, F., & The Cooperative Multicentric Group (1994) · Movement Disorders · doi:10.1002/mds.870090112 · Cited by 796
Self-citationNon‐motor symptoms in Parkinson’s disease
Poewe, W. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02056.x · Cited by 782
Self-citationChaudhuri, K. R. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.629 · Cited by 676
Self-citationCompulsive buying: descriptive characteristics and psychiatric comorbidity.
Ga, C., Faber, R., de Zwaan, M., Raymond, N. C., Sm, S., Ekern, Tb, M., Crosby, R. D., Sj, C., & Ed, E. (1994) · PubMed · Cited by 664
Peto, V., Jenkinson, C., & Fitzpatrick, R. (1998) · Journal of Neurology · doi:10.1007/pl00007730 · Cited by 576
Parkinson's disease sleep scale—validation of the revised version PDSS‐2
Trenkwalder, C., Kohnen, R., Högl, B., Metta, V., Sixel‐Döring, F., Frauscher, B., Hülsmann, J., Martinez‐Martin, P., & Chaudhuri, K. R. (2011) · Movement Disorders · doi:10.1002/mds.23476 · Cited by 418
Self-citationRopinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease
Pahwa, R., Stacy, M. A., Factor, S. A., Lyons, K. E., Stocchi, F., Hersh, B. P., Elmer, L. W., Truong, D. D., & Earl, N. L. (2007) · Neurology · doi:10.1212/01.wnl.0000258660.74391.c1 · Cited by 290
Katzenschlager, R., Hughes, A., Evans, A., Manson, A. J., Hoffman, M., Swinn, L., Watt, H., Bhatia, K., Quinn, N., & Lees, A. J. (2005) · Movement Disorders · doi:10.1002/mds.20276 · Cited by 286
Honig, H., Antonini, A., Martinez‐Martin, P., Forgacs, I., Faye, G. C., Fox, T., Fox, K., Mancini, F., Canesi, M., Odin, P., et al. (2009) · Movement Disorders · doi:10.1002/mds.22596 · Cited by 274
Self-citationZesiewicz, T. A., Sullivan, K. L., Arnulf, I., Chaudhuri, K. R., Morgan, J. C., Gronseth, G. S., Miyasaki, J., Iverson, D. J., & Weiner, W. J. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d55f24 · Cited by 273
Self-citationMartinez-Martin, P., Rodriguez-Blazquez, C., Abe, K., Bhattacharyya, K. B., Bloem, B. R., Carod-Artal, F. J., Prakash, R., Esselink, R. A. J., Falup-Pecurariu, C., Gallardo, M., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c0d416 · Cited by 262
Self-citationReliability and validity of the Beck depression inventory in patients with Parkinson's disease
Visser, M., Leentjens, A. F. G., Marinus, J., Stiggelbout, A. M., & van Hilten, J. J. (2006) · Movement Disorders · doi:10.1002/mds.20792 · Cited by 223
A Controlled Trial of Rotigotine Monotherapy in Early Parkinson's Disease
(2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1721 · Cited by 203
Sleep disorders in Parkinson’s disease
Stocchi, F., Barbato, L., Nordera, G., Berardelli, A., & Ruggieri, S. A. (1998) · Journal of Neurology · doi:10.1007/pl00007731 · Cited by 150
Eggert, K., Schrader, C., Hahn, M., Stamelou, M., Rüssmann, A., Dengler, R., Oertel, W., & Odin, P. (2008) · Clinical neuropharmacology · doi:10.1097/wnf.0b013e31814b113e · Cited by 128
Etminan, M., Gill, S. S., & Samii, A. (2003) · Drug Safety · doi:10.2165/00002018-200326060-00005 · Cited by 87
Högl, B., Rothdach, A., Wetter, T. C., & Trenkwalder, C. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300250 · Cited by 83
Self-citationEffects of Ropinirole on Nonmotor Symptoms of Parkinson Disease: A Prospective Multicenter Study
Rektorová, I., Baláž, M., Svátová, J., Zárubová, K., Honig, I., Dostal, V., Sedláčková, S., Nestrašil, I., Mastík, J., Bareš, M., et al. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31815d25ce · Cited by 79
Rotigotine transdermal delivery for the treatment of Parkinson's disease
Rascol, O., & Perez‐Lloret, S. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902746041 · Cited by 48
Rotigotine transdermal system for the treatment of Parkinson's disease
Pham, D. Q., & Nogid, A. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.05.007 · Cited by 47
Parkinson's disease sleep scale: Validation study of a Spanish version
Martínez‐Martín, P., Salvador, C., Lm, G., González, S., Tobías, A., Almazán‐Isla, J., & Chaudhuri, К. R. (2004) · Movement Disorders · doi:10.1002/mds.20144 · Cited by 45
Psychometric properties of the Parkinson's Disease Sleep Scale – Brazilian version
Margis, R., Donis, K. C., Schönwald, S. V., Fagondes, S. C., Monte, T. L., Martín-Martínez, P., Chaudhuri, К. R., Kapczinski, F. P., & Rieder, C. R. D. M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.12.008 · Cited by 45
Uemura, Y., Nomura, T., Inoue, Y., Yamawaki, M., Yasui, K., & Nakashima, K. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.015 · Cited by 41
Wang, G., Cheng, Q., Zeng, J., Bai, L., Liu, G.-D., Zhang, Y., Tan, Y., Pan, J., Hong, Z., Wang, Y., et al. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.008 · Cited by 37
Romigi, A., Stanzione, P., Marciani, M. G., Izzi, F., Placidi, F., Cervellino, A., Giacomini, P., Brusa, L., Grossi, K., & Pierantozzi, M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0490-x · Cited by 32
Cited by
Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141
Self-citationFox, S. H., Katzenschlager, R., Lim, S., Barton, B., de Bie, R. M. A., Seppi, K., Coelho, M., Sampaio, C., & on behalf of the Movement Disorder Society Evidence‐Based Medicine Committee (2018) · Movement Disorders · doi:10.1002/mds.27372 · Cited by 1,002
Fox, S. H., Katzenschlager, R., Lim, S., Ravina, B., Seppi, K., Coelho, M., Poewe, W., Rascol, O., Goetz, C. G., & Sampaio, C. (2011) · Movement Disorders · doi:10.1002/mds.23829 · Cited by 523
Self-citationParkinson’s disease: The non-motor issues
Chaudhuri, K. R., Odin, P., Antonini, A., & Martinez-Martin, P. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.02.018 · Cited by 388
Self-citationAdvances in diagnosis, classification, and management of pain in Parkinson's disease
Tinazzi, M., Gandolfi, M., Artusi, C. A., Bannister, K., Rukavina, K., Brefel-Courbon, C., de Andrade, D. C., Perez-Lloret, S., & Mylius, V. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00033-x · Cited by 60
Metadata
- Authors
- Trenkwalder, C., Kies, B., Rudzinska, M., Fine, J., Nikl, J., Honczarenko, K., Dioszeghy, P., Hill, D., Anderson, T., Myllyla, V., Kassubek, J., Steiger, M., Zucconi, M., Tolosa, E., Poewe, W., Surmann, E., Whitesides, J., Boroojerdi, B., Chaudhuri, K. R., & the RECOVER Study Group
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2010-11-18
- Volume
- 26
- Issue
- 1
- Pages
- 90-99
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1990967797
- Cited by
- 437
- References
- 26
- FWCI
- 17.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.